The benefits of pharmaceutical marketing in 2024: Lingering skepticism (notice n° 582635)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01532cam a2200193 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250121141603.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Escobedo, Patricia |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | The benefits of pharmaceutical marketing in 2024: Lingering skepticism |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2024.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 74 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | France’s Haute Autorité de Santé (HAS) (National Authority for Health) has published a report on the interactions between healthcare professionals and pharmaceutical firms, particularly via pharmaceutical detailing. HAS notes that professionals’ exposure to these interactions is early, ubiquitous, and global. According to the methodical summary of studies published between 2004 and 2018 by HAS, the information conveyed by pharmaceutical detailing is of poor quality; and healthcare professionals lack the critical thinking and training to discern its influences on their practice. Various regulatory measures have been introduced in some countries to limit the impact on healthcare. So far, they have been inconclusive. The most effective way of limiting the influence of the pharmaceutical sales force on drug prescribing and dispensing is still to avoid receiving sales reps. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | influence |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | régulation insuffisante |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | tromperie (ou information biaisée) |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Les Tribunes de la santé | o 79 | 1 | 2024-04-17 | p. 45-50 | 1765-8888 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-les-tribunes-de-la-sante-2024-1-page-45?lang=en&redirect-ssocas=7080">https://shs.cairn.info/journal-les-tribunes-de-la-sante-2024-1-page-45?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux